#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Indolent systemic mastocytosis Bronchopulmonary aspergillosis Intracranial calcification Pyoderma gangrenosum Hyperoxaluria Desmoplastic small round cell tumour Chronic hepatitis B Central nervous system neoplasm Glomerulonephritis membranous Follicular lymphoma stage I Epilepsy Trigeminal neuralgia Non-Hodgkin's lymphoma Neonatal alloimmune thrombocytopenia Chordoma More trials…

    Learn about Rare Diseases

    Hereditary angioedema with C1 esterase inhibitor deficiency – Life with Disease Basal cell naevus syndrome Pelizaeus-Merzbacher disease – Diagnostics Glomerulonephritis membranoproliferative – Diagnostics Mantle cell lymphoma stage IV – Diagnostics Indolent systemic mastocytosis – Life with Disease Congenital nephrogenic diabetes insipidus – Diagnostics Thrombotic thrombocytopenic purpura – Treatment Epidermolysis bullosa – Diagnostics Splenic marginal zone lymphoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    VERTEPORFIN Paracetamol Dc Emiplacel Piperacillin ZIRCONIUM (89ZR) GIRENTUXIMAB Fenofibrate Micronised IBANDRONIC ACID Prasterone Dexamethasone Isonicotinate ALENDRONATE SODIUM TRIHYDRATE Terbinafine Retifanlimab Meropenem Anhydrous Clebopride Hydrogen Maleate Corline Heparin Conjugate Vedolizumab Glycopyrronium Bromide Ht-29-A Methadone Hydrochloride FRUQUINTINIB More therapies…

    Learn about Your Condition

    Meniscus injury Breast cancer metastatic Immunodeficiency Rheumatoid arthritis KBG syndrome Mastocytosis Adenovirus infection Malignant glioma Seizure Hyperparathyroidism secondary Osteonecrosis of jaw Naevus flammeus Fragile X syndrome Thymoma Endometrial cancer stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Muscle spasticity

  • Comparison of Pregabalin and Baclofen Treatment in Patients with Spastic Motor Behavior Following Cervical or Thoracic Spinal Cord Injury

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Muscle spasticity
    Investigated Drugs:
    • Baclofen
    • Pregabalin
    Czechia

  • Study on the Safety and Effectiveness of IPN10200 for Treating Upper Limb Spasticity in Adults After Stroke or Brain Injury

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Botulinum Toxin Type A – Haemagglutinin Complex
    • Clostridium Botulinum, Neurotoxin Serotype A/B
    Austria Bulgaria Czechia France Germany Hungary +4

  • Study on Botulinum Toxin Type A for Treating Spastic Equinovarus in First-Time Stroke Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Muscle spasticity
    Investigated Drugs:
    • Botulinum Toxin Type A – Haemagglutinin Complex
    Belgium

  • Study on Riluzole for Reducing Spasticity in Patients with Chronic Spinal Cord Injury

    Recruiting

    3 1
    Investigated Diseases:
    • Muscle spasticity
    Investigated Drugs:
    • Cellulose, Microcrystalline
    • Riluzole
    France

  • Study of individualized doses of botulinum toxin type A (incobotulinumtoxin) in adults with severe spasticity caused by brain damage

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Muscle spasticity
    Investigated Drugs:
    • Botulinum Toxin Type A
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    Spain

  • Study comparing Dry Needling and Botulinum Toxin Type A treatments for leg muscle stiffness in stroke patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Muscle spasticity
    Investigated Drugs:
    • Botulinum Toxin Type A
    Belgium Spain
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!